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Abstract
Objectives-To determine the phenotype
of peripheral blood lymphocytes during
the time-course ofadjuvant arthritis (AA)
to detect alterations that could be involved
in the pathogenesis of the arthritic
process.
Methods-Phenotype analysis was
performed on days 7, 14, 21, 28, 42, 56 and
70 after arthritis induction using mono-
clonal antibodies to CD5, CD4 and CD8
subsets, and flow cytometry. The
proportion of activated lymphocytes and
lymphocytes was also assessed with
monoclonal antibodies to IL-2R (CD25),
to Ia antigen and by polyclonal antibodies
to rat Ig.
Results-Adjuvant arthritis produced
leukocytosis with neutrophilia. Rats with
AA showed a marked increase in the
number ofboth CD4+ and CD8+ cells. The
ratio CD4/CD8 decreased because the rise
in CD8+ cells was more pronounced than
the increase in CD4+ cells. Changes in
lymphocyte counts showed two well-
defined periods: the first, from day 14 to
day 28, during which the inflammation of
the joints reached a maximum and
changes in lymphocyte subsets were more
pronounced, that is, there was a threefold
increase in CD8+ lymphocytes over
normal counts, and the second, from day
42 to day 70, in which modified para-
meters improved considerably but
remained different from controls.
Conclusion-Alterations were detected in
the phenotype of peripheral blood
lymphocytes in AA, which provides an
additional marker of disease activity.
(Ann Rheum Dis 1994; 53: 461-466)
the quantitative relationship of lymphocyte
subpopulations in adjuvant arthritic rats.
The aim of this study is to determine the
phenotype of peripheral blood lymphocytes
during the time-course of adjuvant arthritis to
detect alterations that could be involved in the
pathogenesis of the arthritic process.
Materials and methods
Female Wistar rats (Charles River, Barcelona)
aged 10 weeks and weighing 180-200 g were
housed in cages with free access to commercial
pellet chow (UAR-A-04R) and water ad
libitum. Temperature (21 ± 1°C) and light
cycle (on from 8:00 to 20:00 hours) were
controlled. Housing conditions were clean but
not pathogen free. Animals were left for two
weeks to acclimatise to the housing conditions
before the experiments began.
INDUCTION AND EVALUATION OF ARTHRITIS
AA was induced by a single subplantar'
injection (0- 1 ml) of heat-killed Mycobacterium
butyricum (Difco Laboratories, Detroit, MI)
suspended in mineral oil (5 mg/ml) in the right
hind-paw. A group of untreated animals
matched by age and sex to arthritic animals
were used as healthy controls. The severity of
AA was quantified by the volume increase in
the left hind-paw. On day 0 (before induction)
and subsequently, 7, 14, 21, 28, 42, 56 and 70
days after adjuvant injection, the animals were
weighed, and left- and right-hind-paw volumes
were measured using a mercury plethys-
mometer (Ugo Basile, Milan). On day 14,
those rats whose left-hind-paw volume increase
exceeded the average left-hind-paw volume
increase of the control group plus two standard
deviations, were selected as arthritic rats.
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Adjuvant arthritis (AA) is a well recognised
model of rheumatoid arthritis, developed in
1956 by Pearson.27 It has been extensively used
to study the pathogenesis of inflammatory
arthritis and to assess the action of anti-
inflammatory and anti-rheumatic drugs. AA is
induced in rats by injection of heat-killed
mycobacteria and is characterised by a severe
polyarthritis. The exact antigen that develops
this experimental model is still unknown
although T-cell-mediated mechanisms are
involved in its pathogenesis." Antibodies
against autologous components have been
found in sera of animals with adjuvant
arthritis.6 7 14 Although cell immune mech-
anisms are involved in AA, little is known about
BLOOD SAMPLES
At 7, 14, 21, 28, 42, 56 and 70 days after
arthritis induction rats were anaesthetised with
ether, and blood samples (5 ml) were taken, by
cardiac puncture, into heparin-coated sterile
Venoject vacuum tubes. Blood samples were
taken from 8 healthy control animals and 10
arthritic rats between 8.00 and 9.00 am.
CELL COUNTS
The number of leukocytes from each rat was
determined using a counting chamber (Kova,
ICL Scientific), and differential analysis of
every sample was performed on staining blood
smears.
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CELL SEPARATION, LABELHING AND FLOW
CYTOMETRY
Rat mononuclear cells were isolated, labelled
and analysed by flow cytometry as described
previously.'3 Briefly, rat mononuclear cells
were isolated by Ficoll-Isopaque gradient
centrifugation, using the method of Boyum as
modified by Davidson and Parish,9 adapted to
rat (d = 1-09 x 103 kg/m3). Viability of each
lymphoid cell suspension was assessed using
acridine orange-ethidium bromide staining.
Mononuclear cells (0 5-1 x 106) were
incubated with monoclonal antibodies to CD5
(OX19) as T lymphocyte marker (purchased
from Sera-Lab);8 CD4 (W3/25) as T helper/
inducer marker;33 CD8 (OX8) as T suppressor/
cytotoxic marker;4 Ia molecule (OX6) as
marker of B cells and activated T cells;24 and
CD25 (OX39) as marker of activated T cells26
(these monoclonal antibodies were kindly
provided by Dr A Williams, Oxford, UK).
FITC-conjugated goat F(ab')2 anti-mouse IgG
antibodies (Sigma) were added to stain mouse
monoclonal antibodies. B lymphocytes were
also directly labelled with FITC-conjugated
rabbit anti-rat immunoglobulins (Dako).
Labelled cells were fixed in 1% para-
formaldehyde in saline solution and stored in
the dark at 4°C until analysis. All samples were
analysed within 6 days of lymphocyte labelling,
but determinations performed after 21 days did
not reveal loss of positive fluorescence staining
over time.
The percentage of fluorescent lymphocytes
was determined using a FACScan flow cyto-
meter (Becton Dickinson, Mount View, CA).
Analysis gates were set in such a way that T or
B lymphocytes were selected.'3 Results for each
lymphocyte subset are expressed as a
percentage of positive cells compared with total
lymphocytes and as the number of cells per litre
of blood compared with lymphocyte count.
Statistical analysis was performed by means
of an ANOVA of linear models'9 considering
the following causes of variation: arthritis
(induced animals versus healthy control
animals) and time (day of the study).
Animals in which arthritis had been induced
also gained less weight in the first period after
induction (fig 1B), which was significantly
lower than controls on days 14-42 (p<0 005).
In advanced phases, arthritic weight increases
tended to return to reference values and body
weight was restored at the end of the period
studied. The evolution of both hind-paw
inflammation and body weight increases
showed significant differences between period
1 (days 14-28, maximum systemic inflam-
mation) and period 2 (days 42-70, tendency to
control values) (p<0005).
LEUKOCYTE COUNT AND LEUKOCYTE
DIFFERENTIAL ANALYSIS
From day 7 post-induction there was
leukocytosis (fig 2A), which was more
pronounced in period 1 than in period 2
(p<Ol0001).
In relation to leukocyte differential analysis,
neutrophil and lymphocyte percentages are
shown in fig 2B. The arthritic process did not
modify the percentages of eosinophils or
monocytes, while basophils were virtually
absent. In contrast, from day seven AA
induction produced an increase in neutrophil
percentage (about 300% in relation to control
values on days 14-28, p<0 0001) and a
reduction in lymphocyte percentage (30%
decrease in relation to control values on days
14-28, p<0-0001). Both types of leukocyte
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HIND-PAW INFLAMMATION AND BODY WEIGHT
The injected right-hind-paw volume increases
in induced animals were significantly higher
than control from the first day of induction
(from day 7 to day 70, p<00001) (fig IA).
Left-hind-paw volume increases, which repre-
sent the systemic inflammation, were not
detected until 10-14 days after induction. On
day 14 the incidence of arthritis was 64/70.
The maximum inflammation was seen on days
21 and 28. There was a slight decrease in
systemic inflammation on days 42, 56 and 70,
but without reaching reference values (from
day 14 to day 70; p<00001). From day 14,
two well-defined phases were noted: a first
period or period 1, from day 14 to 28, during
which inflammation of the joints reached a
maximum, and a second phase or period 2,
from day 42 to 70, in which values decreased,
although they remained higher than controls.
30 F
U1)(au)
-C
a)
.5
.:
T T
T
.0-,T
7 14 21 28 35 42 49 56 63 70
B
20 p
10 *
0 p l Il I
7 14 21 28 35 42 49 56 63 70
Days post induction
Figure 1 A) Evolution of right (circles) and left hind-paw
(triangles) volume increases (ml) in arthritic (filled) and
healthy (hollow) animals; B) Evolution ofbody weight
increase in arthritic (0) and healthy (0) animals. Each
point represents the mean (SEM) of8-10 animals.
462
 group.bmj.com on July 22, 2011 - Published by ard.bmj.comDownloaded from 
Blood lymphocyte subsets in rats with adjuvant arthritis
80
60
I- I--...e..0--'
40 F
20
10
8
6
4
2
0
L A
;I;
.3..l
*-0------
7 14 21 28 35 42 49 56 63 70
B
.. ...
......
... 5... .0 ..
- T
TT*-- .----------..............
7 14 21 28 35 42 49 56 63 70
-c
A.44 Q 4^ ....
T
A... A~ ~
~~~~~~.........
7 14 21 28 35 42 49 56 63 70
Days post induction
Figure 2 Leuleocyte count and leukocyte differential
analysis: A) Number ofleukocytes in healthy (0) and
arthritic (@) rats. Percentage (B) and absolute number (C)
of lymphocytes (circles) and neutrophils (triangles) in
healthy (hollow) and arthritic (filled) animals. Each point
represents the mean (SEM) for 8-10 animals.
followed the two well-defined periods in the
evolution of arthritis and the values in these
phases were significantly different (p<OOOO1).
Time-courses of absolute numbers of
neutrophils and lymphocytes are shown in fig
2C. Neutrophils increased significantly in
arthritic animals, up to 10 fold in period 1
(p<O0OOOl), while in period 2 the increase was
only 4 fold (p<OO1). Although the percentage
of lymphocytes diminished in AA, their
absolute number increased significantly, to
double the control values, throughout the
study (p<005). There was a significant
difference between the two periods of the
arthritic process in the time-course of
neutrophil and lymphocyte numbers
(p<0O005).
SUBSETS OF LYMPHOCYTES
Results of B-lymphocyte analysis are shown in
fig 3. B-cells were determined in two ways:
FITC-conjugated anti-Ig and anti-Ia mono-
clonal antibody. The results obtained with
these two labels were similar, and only results
for Ia+ cells are reported. AA induction
increased the absolute number of B lym-
phocytes during period 1 of systemic inflam-
mation (p<0005), but their percentage was
not modified.
The absolute number of CD5+ cells (fig 3)
increased throughout the study (p<OOO1); the
increase was more pronounced in period 1
(maximum systemic inflammation) than in
period 2 (slight remission ofinflammation), the
differences between them being significant
(p<OOl). No difference in CD5+ cell per-
centages was observed between arthritic and
control group.
The absolute number of CD4+ cells (fig 3)
increased in the peripheral blood of adjuvant
arthritic rats (p<OOOl compared with control
values) in a biphasic pattern, following hind
paw inflammation (p<OO 1, difference between
periods). The percentage of CD4+ subset was
not modified by the arthritic process.
Absolute numbers of CD8+ cells (fig 3) were
considerably higher in arthritic animals during
period 1 (p<OOOOl, compared with healthy
control values); they later diminished but did
not reach reference values. The percentage of
CD8+ cells was significantly higher in arthritic
rats, than in healthy animals, on day 14 post-
induction (p<005). The percentage remained
high throughout the maximum inflammation
period or period 1 (p<0-0001). There was a
positive correlation between the percentage of
CD8+ cells and systemic inflammation
measured in left-hind-paw (r = 0-332 1,
p<O - 1). In the last phase studied no difference
in CD8+ lymphocyte percentage, in relation to
healthy animals, was observed. CD4/CD8 lym-
phocyte ratio (fig 4) was significantly lower in
arthritic rats than in healthy rats on days 21
and 28 post-induction (p<0025), reaching
reference values in the last period.
To quantify activated lymphocytes the anti-
IL2R MAb was used. The percentage of
CD25+ cells was always less than 2% (back-
ground value), which indicated the absence of
these cells from the blood of arthritic animals.
Discussion
This study describes the time-course of
phenotypes of peripheral blood lymphocytes in
arthritic rat blood for 70 days after arthritis
induction. Two well-defined periods can be
established in the arthritic process: the first,
from day 14 to day 28 post-induction is
characterised by the onset and establishment of
systemic inflammation and loss ofbody weight,
and the second, from day 42 to day 70, which
corresponds to the chronic phase of the
inflammation in which a tendency toward
reference values was observed. Rats with AA
showed a marked increase in the number of
both CD4+ and CD8+ lymphocytes. The ratio
CD4/CD8 decreased because the rise in CD8+
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Figure3 AbsolutenumberandpercentageofIa',CD5',CD4'andCD8'lymphocytesinhealthy(O)andarth?itic(s)
rats. Each point represents the mean (SEM) for 8-10 animals.
cells was more pronounced than the increase
in CD4' cells. The CD8 counts during the
time-course of adjuvant arthritis followed the
same pattem as the degree of inflammation
measured as hind paw swelling. During the
period in which inflammation of the joints
reaches a maximum CD8' cell counts increase
threefold. However, when articular swelling
diminished, CD8' values improved con-
siderably although they were still higher than
controls.
Adjuvant arthritis is a well-known model of
rheumatoid arthritis. However, to our
knowledge, there have been very few studies on
the phenotype of circulating lymphocytes in
AA. The remarkable shift in phenotype that we
have detected has not been reported
previously, probably because it is more easily
appreciated when absolute counts are
considered.
The CD8 molecule is present in cytotoxic
and suppressor lymphocyte subsets; thus it is
not possible to attribute the percentage
increase in CD8' cells to a determinate
fimction. An increase in CD8' subset has been
reported by Kaufrnann'o in human myco-
bacterial infectious diseases, and was
attributed to cytotoxic activity. Although AA is
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Figure 4 CD4/CD8 lymphocytes ratio in healthy (0) and
arthritic (0) animals. Each point represents the mean
(SEM) for 8-10 animals.
induced by heat-inactivated mycobacteria, a
similar mechanism could be suggested. On the
other hand, the increase in CD8+ cells might
be due to a T-cell bearing gamma-delta
receptors, some of which are CD8+'7 and
recognise mycobacterial determinants.3 29
Although alterations in the number and
percentage ofCD8+ lymphocytes in AA has not
been described before, the role of CD8+
lymphocytes in this experimental model was
studied by Larsson et al,23 who observed that
depletion of the CD8+ subset before AA
induction did not modify the arthritic process.
Other authors, however,' 21 22 have related this
subset to susceptibility and development of
AA. Moreover, Binderup2 has shown that Con-
A-induced T-suppressor cell activity decreased
in rats with AA, and this reduction was found
to coincide with the development of the
polyarthritic lesions. In a recent study on
arthritic rat synovial tissue we observed a
marked increase in CD8+ cells in lining and
subintimal layer, without quantitative
fluctuations in CD4+ cells (Pelegri et al
submitted). Further, a functional study of the
CD8+ cells, the number of which increase in
AA, is required to determine whether there is
an increase in the T-cytotoxic subset (as has
been described in clinical mycobacterial
diseases20) or whether there is an increase in
the T-suppressor subset, but their activity is
reduced.
If we compare our results with those
reported for human RA, some similarities
emerge. Thus the number of CD4+ cells has
been shown to increase32 but also to remain
normal.'0 15 CD8+ cell number was seen to be
similar to'0 12 or lower than" 18 32 healthy
reference values. Other studies do not report
any difference in CD4/CD8 ratio in patients
with RA.10 25 Regarding blood T-lymphocyte
function, contradictory results have also
appeared (reviewed in reference 28).
On the other hand, by means of anti-Ia and
anti-CD25 MAb, activated lymphocytes were
not detected in arthritic rats, although they
have been described in human RA.18 25 30 In
AA, activated T cells have been reported only
in arthritic synovia.23
Our total and differential leukocyte study in
adjuvant arthritis also revealed leukocytosis
with a high percentage of neutrophils and a
high number oflymphocytes. Our data confirm
and complete those of Glenn et al,'6 who
reported leukocytosis, neutrophilia and an
increase in the number of lymphocytes on day
21 post-induction. These changes agree with
results reported by Carlson et al5 on day 49
post-induction, who also found an increase in
monocyte percentage. These fluctuations in
white blood cells are probably secondary to the
inflammatory process present in AA.
In summary, we have detected alterations in
the phenotype of peripheral blood lymphocytes
in AA and its correlation with the inflammatory
process, which provides an additional marker
of disease activity. The specificity of this
expanded population of CD8 cells remains
unknown. Studies in which peripheral blood
lymphocytes and the lymphocytes infiltrating
the synovium are characterised in parallel may
indicate what proportion of these CD8+ are
involved in pathogenesis.
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